NEWSROOM

NASDAQ

AmpliTech Group Reports Q1 FY2025 Results and Signals Positive Outlook with Record Bookings and Strategic IP Advancements

AmpliTech Group Reports Q1 FY2025 Results and Signals Positive Outlook with Record Bookings and Strategic IP Advancements

Provides Full-Year Guidance Forecasting Over 100% Revenue Growth; Highlights Enhanced IP and Corporate Valuation HAUPPAUGE, N.Y., May 15, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leader in the design and manufacture of advanced signal processing components for satellite, public and private 5G, and other communications systems, today reported its financial results for the first quarter ended March 31, 2025. Although Q1 results were not stellar, the company also...

read more
SS Innovations Reports First Quarter 2025 Financial Results

SS Innovations Reports First Quarter 2025 Financial Results

Record Quarterly Revenue of $5.1 Million Driven by Higher SSi Mantra 3 Unit Sales On Track for July 2025 De Novo Application to the FDA for SSi Mantra 3  Fort Lauderdale, FL, May 14, 2025 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced unaudited financial results for the three...

read more
SKYX Reports Record First Quarter 2025 of $20.1 Million Compared to $18.9 Million for First Quarter 2024 as it Continues to Grow its Market Penetration of its Advanced and Smart Platform Products in the U.S and Canadian Markets

SKYX Reports Record First Quarter 2025 of $20.1 Million Compared to $18.9 Million for First Quarter 2024 as it Continues to Grow its Market Penetration of its Advanced and Smart Platform Products in the U.S and Canadian Markets

Company expects its products to be in 30,000 U.S. and Canadian homes by the end of the Second quarter of 2025. Company is Progressing with Significant Projects and Orders that will Enable it to Become Cash Flow Positive in Second Half of 2025 General and Administrative Expenses Decreased by 17% as Compared to the First Quarter of 2024 and Gross Margin and Gross Profit Improvement by 4.8% and 2% in the First Quarter of 2025 Sequentially from the Fourth Quarter of 2024 SKYX Announces Additional...

read more
SKYX Reports Record First Quarter 2025 of $20.1 Million Compared to $18.9 Million for First Quarter 2024 as it Continues to Grow its Market Penetration of its Advanced and Smart Platform Products in the U.S and Canadian Markets

SKYX Announces Additional $4 million in Recent Preferred Stock Funding Representing $2 Per Share from Strategic Investors in a Round Totaling $15 million Led by Global Marriott Hotels Chain Owner The Shaner Group

MIAMI, May 13, 2025 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive advanced and smart home platform technology company for homes and buildings, with more than 97 issued and pending patents globally and a portfolio of over 60 lighting and home décor websites, announced today that it has secured approximately $4 million in recent funding from strategic investors through the purchase of preferred stock representing  $2.00 per share. This investment is...

read more
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

CUPERTINO, Calif., May 13, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity renewable fuels, announced today that its Aemetis Biogas subsidiary has signed a $27 million equipment agreement with Centuri Holdings, Inc. (NYSE: CTRI), a $2.6 billion infrastructure services contractor, to build biogas cleanup systems for 15 dairy digesters. This signed agreement, and expected future agreements...

read more
SKYX Announces Corporate Update Call Including New Developments

SKYX Announces Corporate Update Call Including New Developments

Company to Provide Corporate Updates Including New Developments, First Quarter 2025 Overview and Financial Results; Conference Call to be Held Wednesday, May 14, 2025, at 4:30 P.M. Eastern Time MIAMI, May 12, 2025 - PRISM MediaWire - SKYX (NASDAQ: SKYX) (d/b/a "SKYX Technologies"), a highly disruptive advanced and smart home platform technology company for homes and buildings, with more than 97 issued and pending patents globally and a portfolio of over 60 lighting and home décor websites,...

read more
PRISM MarketView Honors Mental Health Awareness Month with a Spotlight on Emerging Innovators

PRISM MarketView Honors Mental Health Awareness Month with a Spotlight on Emerging Innovators

NEW YORK, May 12, 2025 - PRISM MediaWire - In recognition of Mental Health Awareness Month, PRISM MarketView reaffirms its commitment to highlighting the critical importance of mental health and the ongoing efforts to improve mental well-being across the nation. Established in 1949 by Mental Health America, Mental Health Awareness Month serves to educate the public about mental illnesses, promote mental wellness, and reduce the stigma associated with mental health conditions. This year's...

read more
AmpliTech Group Reports Q1 FY2025 Results and Signals Positive Outlook with Record Bookings and Strategic IP Advancements

AmpliTech Group Achieves FCC Certification For Its 5G ORAN Low Power Radios For Private 5G Deployments In US

Meeting the rigorous US regulatory standards required for deployment locally HAUPPAUGE, N.Y., May 12, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks, including full 5G/6G system design and global distribution of integrated circuit assembly packages and lids, today proudly announces a significant milestone: the...

read more
Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Texas Back Institute is a world leader in advancing spine technology, science, and education, as well as patient care CLARITY is a randomized clinical trial designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) BROOMFIELD, Colo., May 12, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”)...

read more
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis Reports First Quarter 2025 Financial Results

California Ethanol passes $2 billion cumulative revenue milestone Aemetis Biogas increased sales by 10,100 MMBtu compared with same quarter last year Sales of investment tax credits resulted in cash proceeds of $19.0 million during Q1 2025 India Biodiesel received letters of intent in April for an aggregate of $31 million of biodiesel sales to OMCs for delivery in May, June and July of 2025 CUPERTINO, Calif., May 8, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas...

read more
Oncocyte to Release First Quarter 2025 Results on May 12, 2025

Oncocyte to Release First Quarter 2025 Results on May 12, 2025

IRVINE, Calif., May 7, 2025 - PRISM MediaWire - Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that it will report first quarter 2025 financial results after the market closes on Monday, May 12, 2025. Oncocyte will host a live Zoom webinar to discuss the company's financial results at 2:00 p.m. PT that same day. Registration for the live webinar, which will discuss financial results and include Q&A, is required at the following link: Oncocyte Q1...

read more
SS Innovations Reports First Quarter 2025 Financial Results

SS Innovations Reiterates Guidance for First Quarter 2025 and Provides Commentary on Second Quarter 2025 Order Trends

Press Audio Overview: FORT LAUDERDALE, Fla., May 05, 2025 - PRISM MediaWire -  SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today reiterated guidance for the first quarter of 2025. “Following our recent uplisting to Nasdaq, we remain very pleased with the growth trajectory of our business as we conclude...

read more
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis to Review First Quarter 2025 Financial Results on May 8, 2025

CUPERTINO, Calif., May 05, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX) announced that the company will host a conference call to review the release of its first quarter 2025 earnings report: Date: Thursday, May 8, 2025 Time: 11 am Pacific Time (PT) Live Participant Dial In (Toll Free): +1-877-545-0523 entry code 761021 Live Participant Dial In (International): +1-973-528-0016 entry code 761021 Webcast URL: https://www.webcaster4.com/Webcast/Page/2211/52416...

read more
Aclarion Welcomes Advocate Health as CLARITY Trial Site

Aclarion Welcomes Advocate Health as CLARITY Trial Site

Advocate Health actively participates in research studies and is an innovator in technology, including spine The CLARITY trial is designed to demonstrate Nociscan’s ability to improve surgical outcomes for chronic low back pain Nociscan aims to become the gold standard in identifying sources of low back pain through MR Spectroscopy (MRS) and Augmented Intelligence (AI) Press Audio: BROOMFIELD, Colo., May 05, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON,...

read more
SS Innovations Reports First Quarter 2025 Financial Results

SS Innovations Announces Chief Financial Officer Transition

Listened: Thomas Wolff · SS Innovations Announces Chief Financial Officer Transition Fort Lauderdale, FL, May 2, 2025 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Arvind Palaniappan as the Company’s Interim Chief Financial Officer, effective May 1, 2025,...

read more
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis Biogas Completes $1.6 million of LCFS and D3 RIN Sales in April

Increasing revenues from Low Carbon Fuel Standard credits and federal D3 RINs Listened: CUPERTINO, Calif., May 01, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced today that the Aemetis Biogas subsidiary of the company completed $1.6 million of sales of California Low Carbon Fuel Standard (LCFS) credits and federal Renewable Fuel Standard D3 Renewable Identification Numbers (D3 RINs) during April 2025. The LCFS...

read more
NextNRG Expands Services into Oklahoma

NextNRG Expands Services into Oklahoma

Expansion begins with one of the nation’s largest in-house fleet operators and supports broader rollout to additional national accounts and new markets across the state MIAMI, April 30, 2025 – PRISM MediaWire - NextNRG, Inc. (“NextNRG” or the “Company”) (Nasdaq: NXXT), a pioneer in AI-driven energy innovation—transforming how energy is produced, managed, and delivered through its advanced Utility Operating System, smart microgrid technology, wireless EV charging, and on-demand mobile fuel...

read more
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis to Benefit From EPA’s Approval of 15 Percent Ethanol Blend

Consumers are expected to save up to $0.20 per gallon at the pump Listened: CUPERTINO, Calif., April 29, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced today that the U.S. Environmental Protection Agency (EPA) issued a waiver allowing a 15 percent blend of ethanol (E15) to continue to be sold after May 1st which will benefit the company through increased demand and sales of the renewable fuel nationwide. The...

read more
Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana

Expands access to first customer using Philips MR Spectroscopy (MRS), demonstrating ease of Nociscan integration across multiple MRS platforms Nociscan now commercially available at 17 sites covering eight states and four countries  Listen: Broomfield, CO, April 29, 2025 – PRISM MediaWire - Aclarion, Inc.,(“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help...

read more
AmpliTech Group Reports Q1 FY2025 Results and Signals Positive Outlook with Record Bookings and Strategic IP Advancements

AmpliTech Group Division AmpliTech Inc Receives Division Record Purchase Orders Of $2 Million From Fortune 500 Company

Also Announces Company’s Record Backlog Of $19.8 Million, All Deliverable In FY2025! Listen: Hauppauge, NY, April 28, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks, including full 5G/6G system design and global distribution of integrated circuit assembly packages and lids, today is proud to announce a landmark...

read more
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis India Begins Biodiesel Shipments to Oil Marketing Companies under $31 Million Allocation For the Next Three Months 

Listen: CUPERTINO, Calif., April 24, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced the Company’s subsidiary in India, Universal Biofuels, today began shipments to fulfill multiple orders for more than 33,000 kiloliters of biodiesel from the government-owned Oil Marketing Companies (OMCs) for an aggregate of $31 million for delivery during May, June, and July.   Additional OMC orders are expected throughout the...

read more
SS Innovations Reports First Quarter 2025 Financial Results

SS Innovations to Uplist to Nasdaq

Listened: Fort Lauderdale, FL, April 24, 2025 - PRISM MediaWire - SS Innovations International, Inc. (the “Company” or “SS Innovations”) (OTC: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced that the Company’s common stock has been approved for listing on The Nasdaq Capital Market® ("Nasdaq").  Trading on Nasdaq is expected to commence on April 25, 2025, and the Company’s shares...

read more
Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”

Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”

Joint meeting to be held in Las Vegas, May 14-17 Presentation will be delivered by Dr. Alessandro Villa of Miami Cancer Institute Topline study results demonstrate clinically meaningful improvements in OLP Visible lesion resolution during treatment; return toward baseline post-dosing supports localized activity Listen: PITTSBURGH, April 23, 2025 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) ("Lipella," "we," "our," or the "Company"), a clinical-stage biotechnology company...

read more
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis India Plant Visited by U.S. Consul General

Listen: CUPERTINO, Calif., April 23, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced the Company’s subsidiary in India, Universal Biofuels, has been working with the U.S. government to support the success of American interests in India. Aemetis owns and operates an 80 million gallon per year biodiesel production facility in Kakinada, Andhra Pradesh. The U.S. Consul General, Jennifer Larson, recently toured the...

read more
Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025

Broomfield, CO, April 23, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, will be presenting at the Planet MicroCap Showcase: VEGAS 2025 in partnership with MicroCapClub on Wednesday, April 23, 2025 at 12:30 PM ET. Brent Ness, Chief Executive Officer of Aclarion, will...

read more
Lipella Pharmaceuticals Abstract on Oral Lichen Planus Treatment Accepted for Podium Presentation at 2025 AAOM/EAOM International Meeting Conference on “Global Transformation in Oral Medicine”

Lipella Reports Positive Phase 2a Results from Second LP-310 Cohort in Oral Lichen Planus; Final Data Expected Q2 2025

Second Cohort Results Highlight Efficacy Across All Key Measures and Reinforce Safety of Twice-Daily Oral Rinse Phase 2a Study Now Fully Enrolled Across All Three Dose Cohorts Advancing Toward Phase 2b IND Submission and Broader Regulatory Engagement Listen: PITTSBURGH, April 22, 2025 - PRISM MediaWire - Lipella Pharmaceuticals Inc. (Nasdaq: LIPO) (“Lipella,” “our,” “us,” or the “Company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today...

read more
AmpliTech Group Reports Q1 FY2025 Results and Signals Positive Outlook with Record Bookings and Strategic IP Advancements

AmpliTech Group Achieves REACH and RoHS Certification For Its 5G ORAN Low Power and Mid Power Radios, Reinforcing Commitment to Sustainability and Compliance

Meeting the rigorous regulatory standards required by international markets Listen: HAUPPAUGE, N.Y., April 21, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks, including full 5G/6G system design and global distribution of integrated circuit assembly packages and lids, today is proud to announce that its 5G ORAN...

read more
Aemetis Biogas Signs $27 Million Agreement with Centuri to Build Gas Cleanup Systems for 15 Dairy Digesters

Aemetis India Plant Receives $31 million of Biodiesel Orders from OMCs for Delivery in Next Three Months

Listen: CUPERTINO, Calif., April 21, 2025 - PRISM MediaWire - Aemetis, Inc. (NASDAQ: AMTX), a diversified global renewable natural gas and biofuels company, announced the Company’s subsidiary in India, Universal Biofuels, received multiple orders for an aggregate of $31 million for the delivery during May, June and July of more than 33,000 kiloliters of biodiesel to the three government-owned Oil Marketing Companies (OMCs).   Additional OMC orders are expected throughout the year in order to...

read more
Aclarion Announces Texas Back Institute as New CLARITY Trial Site

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis

Independent Cost-Effectiveness Analysis Concludes Nociscan is Effective and Less Costly Compared to Provocative Discography Conclusions Illustrate Nociscan Saves $1,712 per Patient and Improves Surgical Success by 10% Listen: BROOMFIELD, Colo., April 21, 2025 - PRISM MediaWire - Aclarion, Inc., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians...

read more
AmpliTech Group Reports Q1 FY2025 Results and Signals Positive Outlook with Record Bookings and Strategic IP Advancements

AmpliTech Group’s 5G Division Secures Company-Record Approx. US$11 Million Purchase Orders As Part Of A New Multi-Year LOI From Tier 1 North American MNO

HAUPPAUGE, N.Y., April 16, 2025 - PRISM MediaWire - AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a leading designer, developer, and manufacturer of advanced signal processing components for satellite, public and private 5G, and other communications networks, including full 5G/6G system design and global distribution of integrated circuit assembly packages and lids, today announced the receipt of company-record Purchase Orders valued at approximately US$11 million. These orders are part of a...

read more

Contact Us

PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850